ALEXUS BLACK: Open Payments
NPI 1538741343 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 64 payments from 30 companies in 2025. Trend: 2023 $864 · 2024 $1,429 · 2025 $1,581
Food & beverage: $1,493Education: $87
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $266 |
| Janssen Biotech, Inc. | 5 | $122 |
| GlaxoSmithKline, LLC. | 5 | $121 |
| Merck Sharp & Dohme LLC | 4 | $115 |
| Incyte Corporation | 2 | $103 |
| ABBVIE INC. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Kite Pharma, Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| Gilead Sciences, Inc. | 3 | $56 |
Products named: KEYTRUDA, KISQALI, ENHERTU, RYBREVANT, Yescarta, LIBTAYO, LUTATHERA, JEMPERLI.
Industry payments across FL — which companies pay providers there.
